RECRUITING

Lupus Landmark Study: A Prospective Registry and Biorepository

Talk to us

Conditions

Systemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Official Title

Lupus Nexus Landmark Study: A Prospective Registry and Biorepository

Quick Facts

Study Start:2023-06-28
Study Completion:2033-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05934149

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 110 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Able to understand and comply with study procedures and voluntarily sign a written informed consent document
  2. * Age 18 years or older at the time of enrollment
  3. * Fulfill criteria for SLE based on one or more of the following classifications systems:
  1. * Not able to obtain consent
  2. * Not able to meet protocol visit requirements
  3. * Pregnant at the time of enrollment

Contacts and Locations

Study Contact

Lupus Nexus Director
CONTACT
646-884-6084
lupusnexus@lupusresearch.org

Principal Investigator

Sam Lim, MD, MPH
PRINCIPAL_INVESTIGATOR
Emory University
Arezou Khosroshahi, MD
PRINCIPAL_INVESTIGATOR
Emory University
Alfred Kim, MD, PhD
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35205
United States
Wallace Rheumatic Studies Center
Los Angeles, California, 90048
United States
Emory University
Atlanta, Georgia, 30322
United States
University of Chicago Medicine
Chicago, Illinois, 60637
United States
University of Massachusetts Memorial Health
Worcester, Massachusetts, 01605
United States
Northwell Health
New York, New York, 11021
United States
SUNY Upstate
Syracuse, New York, 13210
United States
UNC Chapel Hill
Chapel Hill, North Carolina, 27599
United States
UT Southwestern Medical Center
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: Lupus Research Alliance

  • Sam Lim, MD, MPH, PRINCIPAL_INVESTIGATOR, Emory University
  • Arezou Khosroshahi, MD, PRINCIPAL_INVESTIGATOR, Emory University
  • Alfred Kim, MD, PhD, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-28
Study Completion Date2033-12

Study Record Updates

Study Start Date2023-06-28
Study Completion Date2033-12

Terms related to this study

Additional Relevant MeSH Terms

  • Systemic Lupus Erythematosus (SLE)
  • Lupus Nephritis
  • Neuropsychiatric Systemic Lupus Erythematosus